Jones Day's PTAB Litigation Blog, Home page
IPR Appeal Dismissed After Biosimilar Development Discontinued

IPR Appeal Dismissed After Biosimilar Development Discontinued

By Jihong Lou, Ph.D. and Cary Miller, Ph.D. Article III of the Constitution imposes a “case or controversy” limitation on the jurisdiction of federal courts:  an actual case or controversy must exist between the parties at all stages of the federal court proceedings,...

read more
A New Game: Better PTAB Defense Litigation Strategies

A New Game: Better PTAB Defense Litigation Strategies

Patent Trial and Appeal Board, or PTAB, defense litigation strategies continue to evolve. In a recent Law360 article, Jones Day Intellectual Property lawyers Dave Cochran, Mike Hendershot, and Matt Johnson explained why previous assumptions and strategies pertaining...

read more
Joined Parties Have Statutory Standing To Appeal

Joined Parties Have Statutory Standing To Appeal

By: Jennifer L. Swize and Daniel Kazhdan In Friday’s decision in Mylan Pharmaceuticals Inc. v. Research Corp. Technologies, Inc., No. 17-2088 (Fed. Cir. Feb. 1, 2019), the Federal Circuit held that a time-barred petitioner that is joined into a case has an independent...

read more

About this blog

Follow us on Twitter

Archives